<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/65545" />
  <subtitle />
  <id>http://dspace.bsuedu.ru/handle/123456789/65545</id>
  <updated>2026-04-07T14:06:22Z</updated>
  <dc:date>2026-04-07T14:06:22Z</dc:date>
  <entry>
    <title>Nonclassical cardiovascular effects of imidazoline receptor agonists</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/65895" />
    <author>
      <name>Stepenko, Yu. V.</name>
    </author>
    <author>
      <name>Shcheblykina, O. V.</name>
    </author>
    <author>
      <name>Peresypkina, A. A.</name>
    </author>
    <author>
      <name>Shmigerova, V. S.</name>
    </author>
    <author>
      <name>Yomna Y.O.M. Akhmed</name>
    </author>
    <author>
      <name>Danilenko, A. P.</name>
    </author>
    <author>
      <name>Lyapkalov, N. S.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/65895</id>
    <updated>2025-11-18T00:01:54Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: Nonclassical cardiovascular effects of imidazoline receptor agonists
Authors: Stepenko, Yu. V.; Shcheblykina, O. V.; Peresypkina, A. A.; Shmigerova, V. S.; Yomna Y.O.M. Akhmed; Danilenko, A. P.; Lyapkalov, N. S.
Abstract: In general, the totality of data available to date indicates a high expediency of including imidazoline receptors in the repertoire of pharmacological targets, the impact on which can affect not only soft, but also hard endpoints in the treatment of cardiovascular pathology</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>A drug as a two-faced Janus: dose-effect, adverse events</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/65894" />
    <author>
      <name>Skachilova, S. Ya.</name>
    </author>
    <author>
      <name>Simakina, E. A.</name>
    </author>
    <author>
      <name>Denisenko, A. V.</name>
    </author>
    <author>
      <name>Shilova, E. V.</name>
    </author>
    <author>
      <name>Motailo, A. L.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/65894</id>
    <updated>2025-11-18T00:01:58Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: A drug as a two-faced Janus: dose-effect, adverse events
Authors: Skachilova, S. Ya.; Simakina, E. A.; Denisenko, A. V.; Shilova, E. V.; Motailo, A. L.
Abstract: In the pharmaceutical industry, the 21st century was marked by the creation of new highly effective drugs: synthetic, immunobiological, genetic engineering, etc. Pharmacotherapy with highly effective drugs leads to a detailed study of their safety and pharmacoepidemiological studies, both in our country and abroad</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Comparison of CD-1 and ICR mouse strains for impulsivity in the enriched cross-maze test: Effects of atomoxetine</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/65893" />
    <author>
      <name>Salimov, R. M.</name>
    </author>
    <author>
      <name>Sukhorukova, N. A.</name>
    </author>
    <author>
      <name>Kovalev, G. I.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/65893</id>
    <updated>2025-11-18T00:01:56Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: Comparison of CD-1 and ICR mouse strains for impulsivity in the enriched cross-maze test: Effects of atomoxetine
Authors: Salimov, R. M.; Sukhorukova, N. A.; Kovalev, G. I.
Abstract: The present study is aimed at evaluation of the impulsivity indicators in the enriched cross-maze test employing mice of outbred CD-1 and ICR strains, belonging to different breeding cores</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Role of visfatin, sirtuin 1 and apelin in patients with autism disorder</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/65892" />
    <author>
      <name>Rada, F.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/65892</id>
    <updated>2025-11-18T00:01:52Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: Role of visfatin, sirtuin 1 and apelin in patients with autism disorder
Authors: Rada, F.
Abstract: The aim of the study was to quantify the serum levels of some nitrogen metabolites, sirtuin 1, visfatin, apelin and tumor necrosis factor-alpha in autistic patients and to evaluate their levels in contrast to normal participants</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

